olivLaw · US equity research
Farmmi, Inc. FAMI
Canned, Fruits, Veg, Preserves, Jams & Jellies · SIC 2033 · Vertical: Food products (SIC 203x)
Farmmi, Inc. is a Cayman Islands holding company that, through its Chinese subsidiaries, produces and sells mainly dried edible fungi such as shiitake and Mu Er. Total revenue fell 56.4% in fiscal 2025 from the prior year as market demand weakened, which makes its dependence on a few customers and suppliers relevant for assessing the business.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Farmmi, Inc. (FAMI) stock was 0.10 USD (−1.70% on the day), with market capitalisation 538.9 k USD, beta 0.64, 52-week range 0.10–1.63 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 29.9
- oversold (≤ 30)
- Bollinger (20, 2)
- 0.09 – 0.12
- in the lower half of the band · %B 0.17 · band width 24.3%
- SMA 50 / 200
- 0.12 / 0.91
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.01 / -0.02
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −18.1% | −1.1% | −17.0 pp | — |
| 3 months | −38.6% | −0.5% | −38.1 pp | — |
| 6 months | −91.7% | +4.4% | −96.1 pp | — |
| Year to date | −92.3% | +12.3% | −104.6 pp | — |
| 1 year | −93.2% | +13.5% | −106.8 pp | −4.2% |
| 3 years | −99.4% | +76.4% | −175.8 pp | −32.4% |
| 5 years | −100.0% | +63.7% | −163.7 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.8 m | 28.4 m | 28.4 m | 39.3 m | 99.2 m | 110.4 m | 64.1 m | 28.0 m |
| Revenue YoY | +11.8% | −4.9% | 0.0% | +38.5% | +152.5% | +11.2% | −41.9% | −56.4% |
| Net income | 3.2 m | 813.5 k | 813.5 k | 2.4 m | 2.2 m | 2.5 m | -4.7 m | -53.1 m |
| Net income YoY | −1.5% | −74.8% | 0.0% | +189.7% | −5.6% | +14.4% | −283.0% | unavailable |
| Diluted EPS | 0.27 | -0.03 | 1.25 | 4.51 | 0.77 | 3.61 | -7.88 | -28.92 |
| Diluted EPS YoY | unavailable | −111.1% | unavailable | +260.8% | −82.9% | +368.8% | −318.3% | unavailable |
| net % | 10.8% | 2.9% | 2.9% | 6.0% | 2.2% | 2.3% | -7.3% | -189.8% |
| Free cash flow | -2.8 m | -10.8 m | -1.8 m | -52.9 m | 20.6 m | -75.8 m | -16.8 m | 52.4 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 30 Sept 2025
- Cash
- 804.1 k USD
- Financial debt
- 1.8 m USD
- Net debt
- 1.0 m USD
- Equity
- 123.9 m USD
- Total assets
- 147.0 m USD
- Debt / equity
- 0.01x
- Current ratio
- 9.35x
- ROE
- -36.1%
- ROA
- -31.8%
- FCF margin
- 187.5%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 28.4 m | 39.3 m | 99.2 m | 110.4 m | 64.1 m | 28.0 m | SEC (XBRL)· 10 Feb 2026verified |
| Cost of revenue | 23.7 m | 34.2 m | 93.8 m | 106.1 m | 60.3 m | 27.2 m | SEC (XBRL)· 10 Feb 2026verified |
| Gross profit | 4.7 m | 5.1 m | 5.4 m | 4.3 m | 3.9 m | 801.5 k | SEC (XBRL)· 10 Feb 2026verified |
| Operating income | 2.3 m | 2.9 m | 942.4 k | 2.0 m | 795.7 k | -56.1 m | SEC (XBRL)· 10 Feb 2026verified |
| Depreciation & amortisation | 65.2 k | 68.4 k | 200.0 k | 200.0 k | 200.0 k | 200.0 k | SEC (XBRL)· 10 Feb 2026verified |
| EBITDA | 2.3 m ≈ | 2.9 m ≈ | 1.1 m ≈ | 2.2 m ≈ | 995.7 k ≈ | -55.9 m ≈ | SEC (XBRL)· 10 Feb 2026derived |
| Interest expense | 168.7 k | 73.9 k | 134.1 k | 650.8 k | 700.0 k | — | SEC (XBRL)· 24 Jan 2025verified |
| Pre-tax income | 1.1 m | 2.4 m | 2.1 m | 2.9 m | -4.6 m | -53.4 m | SEC (XBRL)· 10 Feb 2026verified |
| Income tax | 16.8 k | -25.6 k | -118.4 k | 313.5 k | 264 | 42 | SEC (XBRL)· 10 Feb 2026verified |
| Net income | 813.5 k | 2.4 m | 2.2 m | 2.5 m | -4.7 m | -53.1 m | SEC (XBRL)· 10 Feb 2026verified |
| Diluted EPS | 1.25 | 4.51 | 0.77 | 3.61 | -7.88 | -28.92 | SEC (XBRL)· 10 Feb 2026verified |
| Weighted average diluted shares | 649.8 k | 522.3 k | 2.9 m | 704.4 k | 590.7 k | 1.8 m | SEC (XBRL)· 10 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 481.9 k | 59.3 m | 41.2 m | 12.8 m | 486.5 k | 804.1 k | SEC (XBRL)· 10 Feb 2026verified |
| Receivables | 10.5 m | 24.5 m | 16.4 m | 24.7 m | 32.5 m | 13.1 m | SEC (XBRL)· 10 Feb 2026verified |
| Inventories | 123.9 k | 1.4 m | 716.3 k | 3.9 m | 5.5 m | 1.5 m | SEC (XBRL)· 10 Feb 2026verified |
| Current assets | 37.0 m | 155.3 m | 153.3 m | 158.2 m | 161.9 m | 93.1 m | SEC (XBRL)· 10 Feb 2026verified |
| Property, plant & equipment, net | 38.9 k | 79.5 k | 44.9 k | 24.5 k | 42.3 k | 36.8 k | SEC (XBRL)· 10 Feb 2026verified |
| Intangibles (excl. goodwill) | 80.6 k | 40.1 k | 6.7 k | 0 | 9.3 m | 9.0 m | SEC (XBRL)· 10 Feb 2026verified |
| Total assets | 38.2 m | 165.7 m | 163.8 m | 174.8 m | 186.7 m | 147.0 m | SEC (XBRL)· 10 Feb 2026verified |
| Accounts payable | — | — | 197.1 k | 1.1 m | 70.0 k | 15.7 k | SEC (XBRL)· 10 Feb 2026verified |
| Short-term debt | 588.0 k | 2.2 m | 0 | 2.4 m | 0 | 0 | SEC (XBRL)· 10 Feb 2026verified |
| Long-term debt | — | 142.3 k | 292.3 k | 1.7 m | 2.2 m | 1.8 m | SEC (XBRL)· 10 Feb 2026verified |
| Current liabilities | 8.4 m | 4.1 m | 8.3 m | 10.7 m | 10.1 m | 10.0 m | SEC (XBRL)· 10 Feb 2026verified |
| Total liabilities | 9.0 m | 4.9 m | 9.1 m | 12.8 m | 16.7 m | 23.2 m | SEC (XBRL)· 10 Feb 2026verified |
| Equity | 29.2 m | 160.8 m | 154.7 m | 162.0 m | 170.0 m | 123.9 m | SEC (XBRL)· 10 Feb 2026verified |
| Shares outstanding at year end | 20.5 m | 557.8 m | — | 6.1 m | 10.7 m | 5.5 m | SEC (XBRL)· 10 Feb 2026verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.6 m | -52.9 m | 20.6 m | -75.8 m | -16.8 m | 52.5 m | SEC (XBRL)· 10 Feb 2026verified |
| Capex | 165.0 k | 4.7 k | 2.9 k | 314 | 29.5 k | 16.7 k | SEC (XBRL)· 10 Feb 2026verified |
| Free cash flow | -1.8 m ≈ | -52.9 m ≈ | 20.6 m ≈ | -75.8 m ≈ | -16.8 m ≈ | 52.4 m ≈ | SEC (XBRL)· 10 Feb 2026derived |
| Investing cash flow | -247.2 k | -12.3 m | -42.0 m | 35.9 m | 2.1 m | -59.7 m | SEC (XBRL)· 10 Feb 2026verified |
| Financing cash flow | 3.2 m | 122.4 m | 11.6 m | 11.0 m | 1.8 m | 7.6 m | SEC (XBRL)· 10 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 43.8% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 538.9 k USD
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
44% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 167.89 – 401.06 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)167.89 – 401.06 (Mid 234.86)WACC 6.0% · starting FCFF 53.0 m USD · terminal value share of EV 84%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: no growth between −30% and +40% justifies the price
- Peers: EV/EBITDAunavailable · the base of the ratio is not positive
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 43.8% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | -31.8% | 0 (vs peers) | 24% |
| Net margin · Quality | -189.8% | 14 (vs peers) | 14% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -34.4% | 0 (on a fixed band) | 19% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -80.2x | 0 (on a fixed band) | 14% |
| Current ratio · Balance sheet | 9.4x | 100 (on a fixed band) | 10% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 9,732.5% | 100 (on a fixed band) | 19% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality5/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partial100/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
FARMMI, INC. (FAMI). Latest full fiscal year: 2025; data up to 2025-09-30.
Figures computed from the financial statements: revenue 28.0 m USD in 2025; YoY growth -56.4%; net margin -189.8%; ROE -36.1%.
The estimated value range is 167.89–401.06 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 234.86 USD, the price of 0.10 USD leaves a potential of 238,824.9% (value / price − 1) and a margin of safety of 100.0% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 43.8% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Current ratio: 9.4x
- FCF yield: 9,732.5%
- The price is below the estimated value range
What contradicts it
- ROIC: -31.8%
- Net margin: -189.8%
- Revenue CAGR 3Y: -34.4%
- Interest coverage: -80.2x
Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Food products (SIC 203x) · same industry group (3-digit SIC) · compared with 7 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| KHCKraft Heinz Co | 30.1 bn | — | -9.0% | -14.0% | −3.5% | −0% / −28% |
| SJMJ M SMUCKER Co | 14.1 bn | 61.6 | 3.9% | 2.5% | +3.7% | +27% / +21% |
| LWLamb Weston Holdings, Inc. | 7.8 bn | 30.8 | 14.2% | 3.8% | +2.5% | −4% / −43% |
| MZTIThe Marzetti Company | 3.1 bn | 17.7 | 16.8% | 9.1% | +1.1% | −33% / −32% |
| BRFHBarfresh Food Group Inc. | 8.8 m | — | -364.2% | -17.9% | +32.6% | −83% / −61% |
| PLAGPlanet Green Holdings Corp. | 5.2 m | — | -706.0% | -308.0% | −35.2% | −86% / −89% |
| FAMIFarmmi, Inc. | 538.9 k | — | -36.1% | -189.8% | −56.4% | −93% / −99% |
| SENEASeneca Foods Corporation | — | — | 12.2% | 5.6% | +8.2% | +21% / +200% |
1- and 3-year price returns: for FAMI from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 10 Feb 2026; since then the company filed 6-K (27 Aug 2026), 6-K (12 Aug 2026), 6-K (06 Jul 2026), 6-K (22 Jun 2026), 6-K (29 May 2026), 6-K (06 May 2026).
In brief
Farmmi, Inc. is a Cayman Islands holding company that, through its Chinese subsidiaries, produces and sells mainly dried edible fungi such as shiitake and Mu Er. Total revenue fell 56.4% in fiscal 2025 from the prior year as market demand weakened, which makes its dependence on a few customers and suppliers relevant for assessing the business.1
SWOT
Strengths
- Premium product quality recognised by customers, and experience in processing and packaging dried mushrooms.
- Long-standing relationships with family-farm suppliers and cooperatives in the Lishui area.
- Own processing facilities and the ability to store mushrooms to manage raw material costs.
Weaknesses
- Heavy dependence on edible fungi, with limited product and business diversification.
- High concentration of sales on few customers and purchases on few suppliers.
- Sharp decline in revenue and volumes in fiscal 2025 as demand weakened.
Opportunities
- Growth potential if mushroom consumption in China moves closer to levels in developed countries.
- Expansion into international markets, including through the California subsidiary, could diversify revenue sources.
- Government support for agriculture and edible fungi could support expansion of the product range.
Threats
- Changes in government policy or loss of tax exemptions could raise costs and reduce margins.
- Intense competition in a fragmented market with low entry barriers could pressure prices.
- Disease, pests and extreme weather affecting mushrooms grown by suppliers could disrupt supply.
Risks
- Customer dependencehigh
Losing its main customer, Shanghai Yunmihui Supply Chain Group, which accounted for most of revenue, could significantly reduce sales and profitability.1
- Supplier concentrationhigh
Raw material purchases come from a limited number of suppliers, and losing any of them could raise costs and affect operating results.1
- Chinese regulationmedium
The food industry is extensively regulated, and failure to comply with food safety laws could lead to fines, suspension of operations or loss of licences.1
- Lack of diversificationmedium
Operations focus on edible fungi, so any risk affecting that industry could have a disproportionate effect on the company.1
- China corporate structuremedium
The company previously operated through a VIE structure, and if Chinese authorities find the structure does not comply with regulations, the value of the shares could decline.1
Investment thesis
What would need to be true (bull case)
- If demand for edible fungi in China keeps growing and consumption moves toward developed-country levels, the company could regain lost volume.
- Its experience in selecting, dehydrating and packaging mushrooms, together with supplier relationships, could support a recovery in margins.
- Expansion into overseas markets and government support for agriculture could open new revenue sources.
What would break the thesis
- A revenue drop of more than half in fiscal 2025 points to weak demand that could persist if the industry moves into maturity.
- Dependence on one major customer and a few suppliers could turn the loss of any relationship into a significant shock to operations.
- Competition in a fragmented market could force price cuts and compress margins, especially if larger rivals keep selling more cheaply.
What to watch
- Trend in shiitake and Mu Er volumes versus fiscal 2025next 10-K
- Share of the main customer in total revenuenext 10-K
- Changes to Chinese regulations or agricultural tax exemptions2027
- Any new overseas sales channels, including via the California subsidiary2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 10 Feb 2026; since then the company filed 6-K (27 Aug 2026), 6-K (12 Aug 2026), 6-K (06 Jul 2026), 6-K (22 Jun 2026), 6-K (29 May 2026), 6-K (06 May 2026).
The business
Farmmi produces and sells agricultural products, mainly edible fungi such as shiitake and Mu Er, along with cotton, corn and forestry products. The company does not grow fungi itself; it buys dried product from third-party suppliers, mainly family farms and the cooperatives Jingning Liannong and Qingyuan Nongbang, then selects, re-dehydrates where needed and packages it in its own processing facilities. Products are sold through distributors to supermarkets, produce distributors and foodservice operators.1
Sales are almost entirely in mainland China, at 98.66% in fiscal 2024, with the remainder exported to the U.S., Japan, Canada and other countries through distributors.1 The company also set up a subsidiary in Newark, California, which it uses as a platform to sell agricultural products into North America and North American food products into Asia.1
The company closed several e-commerce channels, including Farmmi Liangpin Market in 2020 and Farmmi Jicai in 2023, indicating a focus on distributor sales and the supply chain.1
Segments
Shiitake mushrooms
Shiitake is the main product by volume; in fiscal 2025 the company sold about 908 tons, a decrease of 588 tons from fiscal 2024 as customers reduced orders.1
Mu Er mushrooms
Mu Er sales in fiscal 2025 were about 746 tons, down 420 tons from the prior year, which the company also attributes to weaker market demand.1
Other agricultural products
The company also trades other agricultural products such as rice and edible oil bought from third-party suppliers, but the source gives no separate figures for these categories.1
Market context
According to the source, China's edible fungi output is growing in both absolute terms and market share, and China has become the largest producer worldwide, although the industry appears to be moving from rapid expansion to a more mature stage. Per-capita consumption in China remains far below the U.S. and Japan, which the company sees as room for growth.1
The company describes the market as fragmented with relatively low barriers to entry, and two major competitors influence prices and volumes, which could limit revenue growth and margins.1
Trends
- Maturing Chinese mushroom industryheadwind
Growth in China's mushroom industry appears to be slowing as the market moves from rapid expansion to maturity, which could reduce the boost to the company's volumes.1
- Lower demand and customer ordersheadwind
Weaker market demand reduced customer orders for both shiitake and Mu Er in fiscal 2025, driving a sharp fall in revenue.1
- Potential demand growth for mushroomstailwind
Per-capita consumption of edible fungi in China is still well below the U.S. and Japan, which the company believes could support longer-term sales.1
- Government support for agriculturemixed
The Chinese government supports agriculture with tax exemptions and local subsidies, and edible fungi are described as a dominant and characteristic industry, though these policies may change.1
Competitive position
The company describes its products as premium quality and competes mainly in the high-end segment. The source nonetheless identifies two major competitors in the area: one with high sales volume that allows lower prices, and another with much larger plants and warehouses focused on Mu Er.1
The market is fragmented and many competitors can offer cheaper products, which could pressure Farmmi's margins if it competes on price.1
- A high-volume edible fungi seller
The source does not name it; it sells fungi at relatively lower prices because of its high sales volume.
- A competitor with larger plants and warehouses
The source does not name it; its main product is Mu Er, in different grades and qualities.
- Regional fungi suppliers and traders
The source mentions many nearby competitors that can offer lower prices to expand their supply.
- Other edible fungi companies
The source gives no further names; it only describes a fragmented market with intense competition.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report (foreign issuer)27 Aug 2026
- Current report (foreign issuer)12 Aug 2026
- Current report (foreign issuer)06 Jul 2026
- Current report (foreign issuer)22 Jun 2026
- Current report (foreign issuer)29 May 2026
- Current report (foreign issuer)06 May 2026
- Current report (foreign issuer)10 Apr 2026
- Current report (foreign issuer)25 Feb 2026
- Annual report (foreign issuer)10 Feb 2026
- Current report (foreign issuer)03 Feb 2026
Sources
- [1] Form 20-F, fiscal year ended 2025-09-30 · SEC / Farmmi, Inc. · 10 Feb 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.